apocell Home Contact Us
  • OVER 175 CLINICAL TRIALS TO DATE


  • contact us
  • News

Illuminating biomarker detection – Leading the way in personalized medicine.

        

2016

2015

  • HS Rugo, J Cortes et. al. Early change in topoisomerase 1 (Top1) positive circulating tumor cells (CTCs) is associated with overall survival (OS) in patients with advanced breast cancer after treatment with etirinotecan pegol” Abstracts P1-13-02: Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 8-12, 2015; San Antonio, TX (http://cancerres.aacrjournals.org/content/76/4_Supplement/P1-13-02)

2014

2012

2009

2005

2004

2003

2002

2001

1999